March 23, 2021
“Iovance Biotherapeutics (IOVA)… The cutting edge med tech has attracted attention from Pantginis’ colleagues, as well. The stock has 5 recent reviews, and all are to Buy, making for a unanimous Strong Buy analyst consensus rating. IOVA has an average… Continue Reading…
February 25, 2021
“TechnipFMC Plc (FTI)… Overall, there are 13 recent reviews on FTI, breaking down 8 to 5 in favor of Buy versus Hold. This makes the analyst consensus rating a Moderate Buy, and suggests that Wall Street generally sees opportunity here. Shares… Continue Reading…
January 7, 2021
“A dozen stocks in the S&P Composite 1500 Pure Value Index, including consumer discretionary firm Ford (F) energy firm Chevron (CVX) and industrials Ryder System (R), are expected to post more than 500% adjusted earnings growth in 2021, analysts say. This is based on an Investor’s… Continue Reading…
December 28, 2020
“Even though U.S. stocks are at all-time highs today, market strategists see the S&P 500 index rising further in 2021, propelled by a stronger economy, robust profit growth, and still-massive stimulus from governments and central banks, which paved the way… Continue Reading…
December 23, 2020
“Heritage Insurance Holdings (HRTG)… Overall, Heritage’s stock retains a Strong Buy rating from the analyst consensus, based on a unanimous 3 recent Buy reviews. The stock is selling for $9.65 and has an average price target of $15, making the one-year… Continue Reading…
December 23, 2020
“Palatin Technologies (PTN)… Overall, Palatin gets a Strong Buy rating from the analyst consensus, and that verdict is unanimous, based on 3 recent Buy reviews. The average price target, $2.17, implies an impressive 417% upside for the coming year… Mustang Bio… Continue Reading…
November 27, 2020
“Benefitfocus (BNFT)… Overall, Wall Street appears to be in agreement with Wieland on BNFT. The stock has a Strong Buy consensus rating, based on 3 Buy reviews and 1 Hold. Shares are selling for $12.50 and the average price target, at… Continue Reading…
October 6, 2020
“Coster remains positive on Nikola and keeps an Overweight (i.e. Buy) rating along with a bullish $41 price target. The analyst, therefore, expects shares to add nearly 70% from current levels… Nikola appears to be the subject of much head… Continue Reading…
October 5, 2020
“SLM Corporation (SLM)… Overall, SLM has a Strong Buy rating from the analyst consensus, based on 4 reviews breaking down to 3 Buys and 1 Hold. The shares are selling for $7.97, and their average price target of $9.33 indicates room… Continue Reading…
Recent Comments